CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe.

CYP2B66, CYP2B618, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe.

Item

http://www.wikidata.org/entity/Q35518558

Q35518558

about

Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade Why Did I Stop? Barriers and Facilitators to Uptake and Adherence to ART in Option B+ HIV Care in Lilongwe, Malawi.Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue.An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African Women Population Pharmacokinetic Modeling To Estimate the Contributions of Genetic and Nongenetic Factors to Efavirenz Disposition.Building Capability for Clinical Pharmacology Research in Sub-Saharan Africa.Brief Report: CYP2B6 516G>T Minor Allele Protective of Late Virologic Failure in Efavirenz-Treated HIV-Infected Patients in Botswana.Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy.Population Pharmacokinetic Model Linking Plasma and Peripheral Blood Mononuclear Cell Concentrations of Efavirenz and Its Metabolite, 8-Hydroxy-Efavirenz, in HIV Patients.Role of Cytochrome P450 2B6 Pharmacogenomics in Determining Efavirenz-Mediated Central Nervous System Toxicity, Treatment Outcomes, and Dosage Adjustments in Patients with Human Immunodeficiency Virus Infection.Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain.Pharmacogenomics for infectious diseases in sub-Saharan Africa: Successes and opportunities.Characterization of Nanodiamond-based anti-HIV drug Delivery to the Brain.Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high HIV and tuberculosis burden countries: a systematic review.Disease burden and the role of pharmacogenomics in African populations.Is there a role of pharmacogenomics in Africa.Long-term efavirenz pharmacokinetics is comparable between Tanzanian HIV and HIV/Tuberculosis patients with the same CYP2B6*6 genotype

P2860

Q28069383-7772D591-9267-478A-AE89-DFF5B5413158 Q28392069-DE9EBBCA-E3EF-4498-A254-A212E6A2511A Q35931175-EEDAD72E-2FCC-495F-B0B2-96955C6498FD Q36093283-304CE405-A1A8-4F84-A63F-D34A13F47437 Q36437792-1CB28A95-BB36-4025-8C88-B33DE3875FA8 Q36966640-A329E85D-2AC3-47A0-BCBB-2C60103EF1EB Q37538760-B14E7D20-8813-428B-9918-21CD0E0F3E39 Q38371653-FF13FB38-F9D7-4F00-907E-924B6BDA2088 Q38686531-C710357D-0312-4DA3-B6DD-E2E33192C7C6 Q38750666-7EEF5973-04C1-49DB-A059-5E327EF8A2D6 Q38755666-7527181F-A341-49FD-9FAD-4CC512D71A53 Q38990321-1CCE324A-E867-4D8B-9ECE-6BE9DFBDB332 Q39944445-5872F17D-2058-4E3B-8194-75C557B1EDCD Q40632449-4068E063-E21E-406F-85EC-B9CEF928A1DA Q47548818-5C1CD638-2841-4250-BAFD-DFBA80656C79 Q52330065-8A47E02C-2846-4BCF-855F-016034C4D058 Q54935902-9BA5CF8B-D445-4EA3-8C31-37F072F519D6 Q54964575-0E7F59A9-5C7F-4D31-94F2-BE33821949EA Q58612379-D0FE4DB8-0749-4122-BE3B-CDE828FAE088

P2860

CYP2B66, CYP2B618, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe.

Item

http://www.wikidata.org/entity/Q35518558

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu